Optimum Perspectives

Optimum Perspectives

By Optimum Strategic CommunicationsBusinessScienceHealth & Fitness
Download on the App Store

Optimum Perspectives episodes

  • How AI is revolutionising drug research
    Listen to expert discussion on the role of AI in drug development, featuring Tushar Pandey, CEO and Co-founder of SimBioSys, and Jeremy Skillington, CEO of Poolbeg Pharma.

    Hosted on Acast. See acast.com/privacy for more information.

    24 min
  • Curve Therapeutics – Addressing challenging drug targets

    Southampton-based Curve Therapeutics recently raised a hefty £40m in a Series A financing round.

     

    In this in-depth podcast, CEO Simon Kerry describes how investors fell in love with Curve’s “Microcycle” based discovery platform, which gives the company “the ability to potentially identify drugs against very difficult, challenging targets”.


    He explains how Curve’s platform enables them to spot drugs with a higher chance of working in real-world conditions. He also outlines the firm’s lead programme – which aims to block two cancer targets called Hypoxia Inducible Factors, or “HIFs”, which enable solid tumours to survive in low-oxygen conditions.


    Speaking to Optimum’s Stephen Adams, Simon ponders the role of luck in securing investment, both “the kind you deserve because you turn over a lot of stones”, and the more fortuitous variety.

    Hosted on Acast. See acast.com/privacy for more information.

    13 min
  • Biotech IPOs make a comeback in 2024
    Listen to the latest insights from Gil Bar-Nahum, Managing Director in the Global Healthcare Investment Banking Group, Jefferies International, on how to succeed in the new wave of biotech IPOs in the Optimum Perspectives podcast.

    Hosted on Acast. See acast.com/privacy for more information.

    21 min
  • Anglonordic Life Science Conference strikes optimistic note for ‘24
    Check out Optimum’s latest Optimum Perspectives Podcast episode featuring the stars of the 20th Anglonordic Life Science Conference in London. Hear industry leaders give their thoughts on trends within the life science industry and the optimistic mood of the markets in 2024!

    Hosted on Acast. See acast.com/privacy for more information.

    10 min
  • The challenges of recruitment for clinical trials
    Diverse recruitment for clinical trials is a huge issue – but what can drug developers do to overcome this challenge? Join Optimum’s Richard Staines as he discuses this thorny issue with Ariceum Therapeutic’s CMO, Germo Gericke, Leucid Bio’s CSO, John Maher and Non-Executive Director & Thought Leader Annalisa Jenkins.

    Hosted on Acast. See acast.com/privacy for more information.

    25 min
  • Lytix Biopharma – Innovations in Killing Cancer
    Following recent encouraging interim clinical results, hear Øystein Rekdal, CEO of Lytix Biopharma, discuss with Optimum's Nick Bastin how the company's lead candidate LTX-315 has a unique approach to killing cancer.

    Hosted on Acast. See acast.com/privacy for more information.

    18 min
  • Tackling Rare Diseases in 2024
    To mark Rare Disease Day on 29 February, Optimum Perspectives podcast interviews a panel of experts who discuss the opportunities and challenges for developers of therapies for rare diseases in 2024. 

    Hosted on Acast. See acast.com/privacy for more information.

    39 min
  • International Day of Women & Girls in Science: Breaking barriers and channeling your inner cavewoman

    In this Optimum Perspectives celebratory episode for International Day of Women & Girls in Science, hear from five influential women on how they broke down gender barriers to succeed in the life science industry.


    Chaired by esteemed journalist Lisa Urquhart, hear guest speakers Renee Aguiar-Lucander of Calliditas, Lene Gerlach of EIR Ventures & WiLD, Bita Sehat of Trill Impact, and Ninna Struck Rossen of Metsystem, share their stories on being women in life sciences, and how to succeed in the industry.

    Hosted on Acast. See acast.com/privacy for more information.

    28 min
  • Optimum's European Life Sciences Investor Survey 2024
    Happy 1st birthday to the Optimum Perspectives Podcast! Since launching, 1000s of listens have grown the show into an excellent hub of intel from top tier life science guests. Listen now to our anniversary special, where Optimum's Mary Clark, Nick Bastin and Eva Haas discuss the findings of our insightful European Life Sciences Investor survey!

    Hosted on Acast. See acast.com/privacy for more information.

    18 min
  • Vicore Pharma: Restoring lung function for IPF patients

    Hear Vicore Pharma’s CEO, Ahmed Mousa speak to Optimum's Richard Staines on their new treatment for Idiopathic Pulmonary Fibrosis (IPF), C21. It aims to improve available treatments for patients of IPF by halting the progression of fibrosis and has the aim of restoring lung function.


    Hosted on Acast. See acast.com/privacy for more information.

    12 min

About Optimum Perspectives

From the publisher's feed

Optimum Insights: Interviews with industry leaders of the healthcare sector in regular episodes highlighting the latest…